Skip to content

Insider · CIK 0001952347

Eugene Frederick Leffler

cfoofficer

Files at BFRI (Biofrontera Inc.). First filing -, latest -.

In brief

Eugene Frederick Leffler files SEC Form 4 as CFO at BFRI (Biofrontera Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Eugene Frederick Leffler has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 10 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jul 28, 2026BFRI
Biofrontera Inc.
MOption exercise
Common Stock
+31,250--206,250Jul 29, 2026
Jul 28, 2026BFRI
Biofrontera Inc.
MOption exercise
Restricted Stock Unitsderivative
-31,250$0.00$031,250Jul 29, 2026
Mar 5, 2026BFRI
Biofrontera Inc.
MOption exercise
Common Stock
+87,500--175,000Mar 6, 2026
Mar 4, 2026BFRI
Biofrontera Inc.
AGrant or award
Restricted Stock Unitsderivative
+62,500$0.00$062,500Mar 6, 2026
Mar 4, 2026BFRI
Biofrontera Inc.
AGrant or award
Employee stock option (right to buy)derivative
+62,500$0.00$062,500Mar 6, 2026
Mar 5, 2026BFRI
Biofrontera Inc.
MOption exercise
Restricted Stock Unitsderivative
-87,500$0.00$00Mar 6, 2026
Sep 10, 2025BFRI
Biofrontera Inc.
MOption exercise
Common Stock
+87,500--87,500Sep 16, 2025
Jul 22, 2025BFRI
Biofrontera Inc.
AGrant or award
Restricted Stock Unitsderivative
+62,500$0.00$062,500Sep 16, 2025
Jul 22, 2025BFRI
Biofrontera Inc.
AGrant or award
Employee stock option (right to buy)derivative
+62,500$0.00$062,500Sep 16, 2025
Sep 10, 2025BFRI
Biofrontera Inc.
MOption exercise
Restricted Stock Unitsderivative
-87,500$0.00$087,500Sep 16, 2025

Questions about Eugene Frederick Leffler

Answered from the filings on this page, as of the latest one.

Is Eugene Frederick Leffler buying or selling?

Eugene Frederick Leffler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Eugene Frederick Leffler's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eugene Frederick Leffler has 0.

Where does Eugene Frederick Leffler file Form 4?

Eugene Frederick Leffler has filed Form 4 at BFRI (Biofrontera Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Eugene Frederick Leffler: insider trades and track record | InsiderTell